Innovative AI techniques are being explored in drug development, potentially transforming the lengthy laboratory-to-pharmacy journey. The promise lies in reducing costs and time, although this advancement raises ethical concerns about the safety and efficacy of AI-derived treatments. Countries involved include the USA and initiatives by companies like Moderna.

Read More:

• 🔗 cosmosmagazine.com